SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels quarterly report sparked a sharp selloff as weaker-than-expected fourth-quarter guidance, continued PC weakness and supply constraints overshadowed stronger data-center and AI growth. Traders are split between calling the drop an overreaction and seeing the outlook as evidence of ongoing execution and earnings risks.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons quarterly report showed slight revenue and earnings misses alongside heavy AI-related capital spending and strained free cash flow, while strong AWS growth did little to prevent a sharp selloff. Traders debated whether the decline was an overreaction and a buying opportunity or a warning that hyperscaler spending and AI returns are under scrutiny.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisks fiscal Q1 results beat estimates and its next-quarter guidance was above consensus; the company also announced an 8-for-1 forward stock split. The muted, volatile share reaction has traders debating a sell-the-news move and broader tech weakness against the view that AI-driven storage demand supports the strong results, while some question how durable the growth will be.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A broad tech selloff tied to mega-cap earnings reactionsespecially Googles decline and pressure in Intel and Amazonhas put QQQ in focus, as traders question whether heavy AI infrastructure spending will generate adequate returns. Some see the selling as overdone or a buying opportunity, while others view it as evidence the AI trade is weakening.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit shares are under pressure after strong third-quarter results were overshadowed by weaker-than-expected fourth-quarter revenue guidance and concerns about declining U.S. daily active users and Google search referrals. Traders debate whether the selloff is an overreaction, while many worry that AI-driven search changes and plans to require logins could further hurt traffic.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians Q3 results beat expectations, with higher delivery guidance and lower planned capital spending, but the stocks weak reaction has kept traders debating whether improving execution can offset continued losses and cash burn. A separate report that Volkswagen is weighing Xpeng software for some vehicles has added concern about Rivians software partnership.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances updated lung-cancer trial results are driving a sharp selloff: the overall response rate held near one in four, while a small biomarker-selected subgroup showed a substantially higher rate. Traders are split between viewing the subgroup findings as a promising precision-treatment strategy and worrying that the mixed data, limited subgroup size, and need for further validation could narrow or delay the regulatory opportunity; many also criticized managements presentation and communication.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategys Q3 results are driving debate: traders note an EPS beat tied largely to Bitcoin gains but a revenue miss, while questioning the quality of earnings and the impact of dilution and preferred-share financing. Bitcoins pullback is adding pressure, though bulls argue MSTRs outlook remains closely tied to BTC and expect a rebound.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbases Q3 earnings are driving discussion, with traders debating the reported profit and market-share gains against weaker transaction activity and concerns that crypto-asset valuation gains inflate headline results. Reactions are mixed, while Bitcoins selloff and broader risk-off trading add pressure and fuel bearish views.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples resilience as AI-heavy tech comes under pressure has fueled talk of a safe-haven rotation into the stock and its role in supporting major indexes. Traders are divided on whether the rally is sustainable ahead of earnings, with valuation concerns and reports of iPhone Duo screen problems weighing on the bearish case.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Glucotrack, Inc. Announces Reverse Stock Split

Glucotrack, Inc. (Nasdaq: GCTK) (Glucotrack or the Company), a healthcare technology and biopharmaceutical company operating Lkahi Therapeutics, today announced that it will effect a 1-for-2 reverse stock split (the Reverse Stock Split) of its issued and outstanding common stock, par value $0.001...

Qare Is Here: Lkahi Therapeutics Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications

Lkahi Therapeutics, a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), today announced the public launch of Qare, a comparative health platform designed to help users compare self-reported treatment experiences across medications within the same therapeutic class. Launching initially in the GLP-1...

Lkahi Therapeutics Expands University of Georgia Collaboration Through First International ai Pipeline Project with Universitt Paderborn

Lkahi Therapeutics, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), today announced a new international project with the University of Georgia's Student Industry Fellows Program and Universitt Paderborn's garage33 entrepreneurship and innovation center. The Fall 2026 initiative represents the...

Lkahi Therapeutics Announces Qare, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14

Lkahi Therapeutics, a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), today announced Qare, a comparative health platform designed to evaluate treatment outcomes by comparing experiences across patients using different medications within the same therapeutic class. Introduced on National GLP-1 Day...

Lkahi Therapeutics Expands ai2 Pipeline Program Through Collaboration with Pepperdine E2B

Lkahi Therapeutics, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), today announced that it will partner with Pepperdine E2B (Education to Business) to engage students in its ai2 Pipeline initiative during the upcoming academic year. The collaboration is intended to provide students with hands-on...

Refinery Restart, $42 Million Greenland War Chest and Big $20 Target: These Stocks Have News

The market is watching a diverse group of companies as catalysts converge. NeOnc Technologies Holdings (NASDAQ:NTHI) attracted fresh Wall Street coverage around its brain-cancer pipeline; Profusa (NASDAQ:PFSA) is moving closer to a potential European regulatory milestone; Sky Quarry (NASDAQ:SKYQ) restarted Nevada's Eagle Springs Refinery; Glucotrack (NASDAQ:GCTK) is turning its Lōkahi asset-discovery platform toward external revenue; while Greenland Mines Ltd. (NASDAQ:GRML) and Greenland Energy Company (NASDAQ:GLND) are advancing separate projects in Greenland.

What's Going On With GlucoTrack Shares On Thursday?

GlucoTrack subsidiary Lokahi Therapeutics secured its first external fee-for-service partnership with nonprofit Innovate GBM for glioblastoma research.read more...

Wall Street Lights the Fuse and These Stocks Just Delivered Market-Moving News

The markets are producing a striking mix of catalysts, with NeOnc (NASDAQ:NTHI), Kraig Biocraft Laboratories (OTCQB:KBLB), Profusa (NASDAQ:PFSA), Sky Quarry (NASDAQ: SKYQ), Glucotrack (NASDAQ:GCTK) and Greenland Mines (NASDAQ:GRML) all generating fresh developments.

Glucotrack, Inc. Announces Pricing of $3 Million Public Offering

Glucotrack, Inc. (NASDAQ: GCTK) (Glucotrack or the Company) today announced the pricing of a best efforts public offering of 169,388 shares of common stock at a price of $2.04 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase up to 1,350,220...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers

Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market session. The company's market cap stands at $1.2 million.
GlucoTrack (NASDAQ:GCTK) stock rose 96.55% to $3.99. Theread more...

This account has been verified as an official GCTK representative.

Verified Account

Glucotrack IR

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

GlucoTrack Inc

GCTK Stock Is Soaring Today — What Is Fueling The Surge?

Equity

Extremely Bullish Sentiment

<ul class="summary-bullets"><li>Glucotrack stated that the company completed its first‑in‑human study in Brazil in 2025 and initiated a follow-up of its study in Australia.</li><li>The company stated that it has built a dual-source U.S. manufacturing strategy with two qualified contract manufacturing partners.</li><li>Glucotrack stated that its first in-human trial met all its primary and secondary endpoints, with a 99% data capture rate.</li></ul>Glucotrack Inc. (GCTK) shares soared more than 26% in Friday’s opening trade after the company announced that it is in a position to file an Investigational Device Exemption (IDE) for its glucose monitoring technology in the second quarter (Q2) with the U.S. Food and Drug Administration.Glucotrack cited critical operational milestones achieved by the company in developing its continuous blood glucose monitoring (CBGM) technology.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/GCTK">Glucotrack</a> trended in the ‘bullish’ territory at the time of writing.<h2 class="st-heading-2">Glucotrack Lists 2025 Milestones</h2>Glucotrack stated that the company completed its first‑in‑human study in Brazil in 2025 and initiated a follow-up of its study in Australia. It said that these updates allow the company to advance toward its clinical program in the U.S.“In 2025, we made meaningful progress in advancing the development of our fully implantable continuous blood glucose monitoring technology and strengthening Glucotrack’s foundation,” said Glucotrack CEO Paul V Goode.Goode added that Glucotrack has also completed extensive U.S. market research across patients and multiple healthcare provider segments. He noted that CBGM is among the fastest-growing segments in the global diabetes market, which remains among the largest in the healthcare industry.The company stated that it has built a dual-source U.S. manufacturing strategy with two qualified contract manufacturing partners, while also identifying a pathway with a compelling economic profile.<h2 class="st-heading-2">In-Human Study Shows Consistent Testing Performance, Says Glucotrack</h2>Glucotrack said that its first in-human study, which was completed in the first quarter (Q1), showed consistent testing performance. The company stated that the trial met all its primary and secondary endpoints, with a 99% data capture rate and a Mean Absolute Relative Difference (MARD) of 7.7% across 122 matched pairs.Glucotrack’s implantable CBGM measures glucose from blood rather than interstitial fluid, thereby eliminating the lag time associated with traditional continuous glucose monitoring systems.<a href="https://stocktwits.com/symbol/GCTK">GCTK stock</a> is down 64% year-to-date and 90% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/huang-nvidia-200-rubin-pods-weekly-wolfe-120-billion-pod-sales-2027-revenue-estimate/cZ3HRwWRIlw">Nvidia CEO Huang’s 200 Rubin Pods A Week Claim Sparks Debate – Here's Why Analysts Aren't Buying The Math</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Glucotrack said it has achieved critical operational milestones in developing its continuous blood glucose monitoring technology.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.39
Prev Close	$2.05
Open	$2.00
Dividend Yield	0.00%
50-Day Moving Average	$4.60
Beta	1.46
Avg. Volume	2.03M
PE Ratio	-0.01

52-Week High	$207.00
52-Week Low	$0.7458
Market Capitalization	$2.43M
EPS (Annual)	-$936.48
Price to Book	-0.25
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

GCTK Fundamentals